Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

McGill University

$105,000.00

The Role of Vps36 in Exosome Production and Infection by Leishmania Parasites

FY 2019-20

Summary
Leishmaniasis is a widespread neglected infectious disease with 0.9-1.6million new cases every year, resulting in up to 40 000 deaths annually. This disease is caused by the Leishmania parasite, carried by the common sandfly whose habitat continues to grow due to climate change, making Leishmaniasis even more widespread. Research performed in our laboratory has led to the discovery that Leishmania secrete tiny particles called exosomes that are injected along with the parasite during a sandfly bite, and these exosomes enhance infection. Exosomes are key to cellular communication, and yet research on their role in infectious diseases is sorely lacking. Knowing their key role in Leishmania infection, we want to test whether inhibiting the release of exosomes by Leishmania will hinder infection and reduce the severity of Leishmaniasis. To accomplish this, we are disrupting a specific gene, Vps36, that has been shown to play a key role in exosome production. This will be done using CRISPR/Cas9 technology, which is capable of targeting specific DNA sequences. This will be used in our case to add an antibiotic resistance gene into the Vps36 gene, disrupting it and allowing for mutant Leishmania to be selected for using antibiotics. We will compare the wild type and mutant Leishmania to test if exosome production is altered. Continuing, we will infect mice with the WT and mutant Leishmania to examine whether Vps36 disruption is sufficient in reducing infection and Leishmaniasis symptoms. The results of this research will clarify the mechanisms of exosome production in Leishmania and potentially create an attenuated strain of Leishmania, which has implications for vaccine development. Additionally, Leishmania themselves may be useful for studying the mechanisms of exosome production present in all eukaryotes, which will be very helpful to cancer and immune cell research.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
416929
Name
dong george
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The Role of Vps36 in Exosome Production and Infection by Leishmania Parasites
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Crispr; Escrt; Exosomes; Immunology; Infection; Leishmaniasis; Macrophages; Mice Studies; Proteomics; Vps36
Abstract
Leishmaniasis is a widespread neglected infectious disease with 0.9-1.6million new cases every year, resulting in up to 40 000 deaths annually. This disease is caused by the Leishmania parasite, carried by the common sandfly whose habitat continues to grow due to climate change, making Leishmaniasis even more widespread. Research performed in our laboratory has led to the discovery that Leishmania secrete tiny particles called exosomes that are injected along with the parasite during a sandfly bite, and these exosomes enhance infection. Exosomes are key to cellular communication, and yet research on their role in infectious diseases is sorely lacking. Knowing their key role in Leishmania infection, we want to test whether inhibiting the release of exosomes by Leishmania will hinder infection and reduce the severity of Leishmaniasis. To accomplish this, we are disrupting a specific gene, Vps36, that has been shown to play a key role in exosome production. This will be done using CRISPR/Cas9 technology, which is capable of targeting specific DNA sequences. This will be used in our case to add an antibiotic resistance gene into the Vps36 gene, disrupting it and allowing for mutant Leishmania to be selected for using antibiotics. We will compare the wild type and mutant Leishmania to test if exosome production is altered. Continuing, we will infect mice with the WT and mutant Leishmania to examine whether Vps36 disruption is sufficient in reducing infection and Leishmaniasis symptoms. The results of this research will clarify the mechanisms of exosome production in Leishmania and potentially create an attenuated strain of Leishmania, which has implications for vaccine development. Additionally, Leishmania themselves may be useful for studying the mechanisms of exosome production present in all eukaryotes, which will be very helpful to cancer and immune cell research.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
dong, george
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McGill University - $105,000 Grant (2019-20) | Canada Spends